U.S. Judicial Panel on Multidistrict Litigation: In re Nexium antitrust litigation [Dr. Reddy's response to motion for transfer]
MLex Summary: Dr. Reddy's Laboratories has filed its response to Meijer's motion to consolidate pay-for-delay litigation over AstraZeneca's Nexium in the District of New Jersey. The company joins AstraZeneca in supporting consolidation...To view the full article, register now.
Already a subscriber? Click here to view full article